Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19.
Clinical Infectious Diseases(2020)
摘要
We provide detailed clinical, virological and immunological data of a B-cell depleted patient treated with obinutuzumab for follicular lymphoma with protracted COVID-19 and viremia. A sustained response was achieved after two courses of remdesivir and subsequent convalescent plasma therapy. Immunocompromised patients might require combined and prolonged antiviral treatment regimens.
更多查看译文
关键词
protracted coronavirus disease,convalescent plasma therapy,remdesivir,sustained response,b-cell
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要